If approved, the prescription is sent to a partner pharmacy
Study Selection The trials we included met the following criteria: (1) RCTs that compared GLP-1 receptor agonist with a placebo or active control (other antidiabetic drugs or insulin), (2) patients with type 2 diabetes, type 1 diabetes, prediabetes, overweight or obesity, (3) with durations of at least 24 weeks, and (4) reported the occurrence of at least one case of various thyroid disorders as adverse events
You will hear two clicks: the first means the injection has started, and the second means it is ongoing
added that Lemonaid now offers weight loss care, prescribing GLP-1
Weight loss medications have transformed obesity management over the last few years, with Semaglutide emerging as one of the most effective treatments available